MedTrace Logo

Clinical Investigation of Healon EndoCoat Ophthalmic Viscosurgical Device (OVD)

NCT05575063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2025-12-12

Study results available
· View outcomes & findings →

Summary

Prospective, multicenter, paired-eye, randomized, subject/evaluator-masked clinical investigation of the experimental EndoCoat OVD versus the control EndoCoat OVD.

Conditions

  • Cataracts

Interventions

DEVICE

Investigational Healon Endocoat

Ophthalmic Viscoelastic device

DEVICE

Control Healon EndoCoat

Ophthalmic Viscoelastic device

Sponsors & Collaborators

  • Johnson & Johnson Surgical Vision, Inc.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Surgical Vision, Inc. Clinical Trial · Johnson & Johnson Surgical Vision, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-08
Primary Completion
2023-12-21
Completion
2023-12-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05575063 on ClinicalTrials.gov